OBJECTIVES: Collection of patient-reported outcome (PRO) measures is critical to fully understand chronic obstructive pulmonary disease (COPD) management and progression, as the impact on health-related quality of life is not well understood by objective measures alone. Electronic PROs (ePROs) are increasingly used because of their advantages over paper data collection, including elimination of transcription errors, increased accuracy and data quality, real-time data reporting, and increased compliance. The objective of this study was to characterize how patients with COPD prefer to use various types of technology to report disease symptoms, and their preferences for ePRO design and display. METHODS: The sample consisted of subjects with COPD (N = 103) who completed in-person surveys on their ePRO preferences. RESULTS: The majority of subjects prefer to use a form of electronic media over paper to report their disease symptoms. Of these electronic methods, subjects most often prefer to use a smartphone provided by their physician. Subjects were also interested in ePRO features, such as knowing estimated PRO completion time at the outset, tracking their progress in real time as they complete a questionnaire, seeing the data that they report in order to track their health status, being encouraged to complete their diary if they fall behind by positive messaging, and being thanked for their completion of a daily diary. CONCLUSIONS: Investigators should consider including these preferences when designing ePRO assessments. Incorporating patient preferences for ePRO design can ultimately help reduce patient burden and increase engagement, compliance, and improve data quality.
OBJECTIVES: Collection of patient-reported outcome (PRO) measures is critical to fully understand chronic obstructive pulmonary disease (COPD) management and progression, as the impact on health-related quality of life is not well understood by objective measures alone. Electronic PROs (ePROs) are increasingly used because of their advantages over paper data collection, including elimination of transcription errors, increased accuracy and data quality, real-time data reporting, and increased compliance. The objective of this study was to characterize how patients with COPD prefer to use various types of technology to report disease symptoms, and their preferences for ePRO design and display. METHODS: The sample consisted of subjects with COPD (N = 103) who completed in-person surveys on their ePRO preferences. RESULTS: The majority of subjects prefer to use a form of electronic media over paper to report their disease symptoms. Of these electronic methods, subjects most often prefer to use a smartphone provided by their physician. Subjects were also interested in ePRO features, such as knowing estimated PRO completion time at the outset, tracking their progress in real time as they complete a questionnaire, seeing the data that they report in order to track their health status, being encouraged to complete their diary if they fall behind by positive messaging, and being thanked for their completion of a daily diary. CONCLUSIONS: Investigators should consider including these preferences when designing ePRO assessments. Incorporating patient preferences for ePRO design can ultimately help reduce patient burden and increase engagement, compliance, and improve data quality.
Authors: Alistair E Ring; Kerry A Cheong; Claire L Watkins; David Meddis; David Cella; Peter G Harper Journal: Patient Date: 2008-04-01 Impact factor: 3.883
Authors: L Araújo; T Jacinto; A Moreira; M G Castel-Branco; L Delgado; A Costa-Pereira; J Fonseca Journal: J Investig Allergol Clin Immunol Date: 2012 Impact factor: 4.333
Authors: Stephen Joel Coons; Chad J Gwaltney; Ron D Hays; J Jason Lundy; Jeff A Sloan; Dennis A Revicki; William R Lenderking; David Cella; Ethan Basch Journal: Value Health Date: 2008-11-11 Impact factor: 5.725
Authors: Heidi S Smith; Andrew J Criner; Dolores Fehrle; Carla L Grabianowski; Michael R Jacobs; Gerard J Criner Journal: Telemed J E Health Date: 2015-10-09 Impact factor: 3.536
Authors: Juan Luis Rodriguez Hermosa; Antonia Fuster Gomila; Luis Puente Maestu; Carlos Antonio Amado Diago; Francisco Javier Callejas González; Rosa Malo De Molina Ruiz; Manuel E Fuentes Ferrer; Jose Luis Álvarez Sala-Walther; Myriam Calle Rubio Journal: JMIR Mhealth Uhealth Date: 2020-03-19 Impact factor: 4.773